BVXP.L
Price:
$3930.943
Market Cap:
$205.18M
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2014-04-29
Stock Exchange
LSE
Ticker
BVXP.L
According to Bioventix PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 199.68M. This represents a change of 1.07% compared to the average of 197.57M of the last 4 quarters.
The mean historical Enterprise Value of Bioventix PLC over the last ten years is 130.82M. The current 199.68M Enterprise Value has changed 15.16% with respect to the historical average. Over the past ten years (40 quarters), BVXP.L's Enterprise Value was at its highest in in the December 2020 quarter at 222.58M. The Enterprise Value was at its lowest in in the January 2011 quarter at 0.
Average
130.82M
Median
158.84M
Minimum
27.09M
Maximum
206.33M
Discovering the peaks and valleys of Bioventix PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 111.40%
Maximum Annual Enterprise Value = 206.33M
Minimum Annual Increase = -13.34%
Minimum Annual Enterprise Value = 27.09M
Year | Enterprise Value | Change |
---|---|---|
2023 | 194.95M | 12.30% |
2022 | 173.59M | -13.34% |
2021 | 200.31M | -2.92% |
2020 | 206.33M | 10.34% |
2019 | 186.99M | 29.77% |
2018 | 144.09M | 57.65% |
2017 | 91.40M | 111.40% |
2016 | 43.23M | 7.63% |
2015 | 40.17M | 48.26% |
2014 | 27.09M | -0.81% |
The current Enterprise Value of Bioventix PLC (BVXP.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
189.62M
5-year avg
192.44M
10-year avg
130.82M
Bioventix PLC’s Enterprise Value is less than AB Dynamics plc (421.70M), less than Craneware plc (1.05B), greater than Tristel plc (191.53M), greater than Somero Enterprises, Inc. (127.46M), less than Focusrite plc (203.26M),
Company | Enterprise Value | Market cap |
---|---|---|
421.70M | $450.80M | |
1.05B | $791.70M | |
191.53M | $190.34M | |
127.46M | $158.82M | |
203.26M | $169.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioventix PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioventix PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bioventix PLC's Enterprise Value?
What is the highest Enterprise Value for Bioventix PLC (BVXP.L)?
What is the 3-year average Enterprise Value for Bioventix PLC (BVXP.L)?
What is the 5-year average Enterprise Value for Bioventix PLC (BVXP.L)?
How does the current Enterprise Value for Bioventix PLC (BVXP.L) compare to its historical average?